CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 32 enrolled
Drug / intervention
Ceftriaxone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04218695
NCT04218695Phase 4Completed

A Pilot Study of the Effect of Prophylactic Antibiotics on Hospitalized Patients With Advanced Cirrhosis

Beth Israel Deaconess Medical Center·interventional·Posted Jan 6, 2020·Updated Mar 3, 2023

In Brief

A Phase 4 clinical trial evaluating Ceftriaxone and Normal saline for Cirrhosis, Liver. Completed, enrolled 32 participants across 1 site.

Detailed Summary

In this pilot study, the investigators aim to assess feasibility of subject identification and data collection, including specimen processing, as well as the rate of enrollment for a future, larger study of the effect of empiric antibiotics for all patients with advanced cirrhosis admitted to the hospital without an existing indication for new antibiotic use. Specifically, the investigators will assess the incidence of infection after the time of enrollment and associated outcomes. Subjects will be randomly assigned to receive antibiotics vs placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedJan 6, 2020
Enrollment StartAug 24, 2020
Primary CompletionMay 31, 2021
Study CompletionAug 28, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 6.5 years ago

Interventions

Ceftriaxonedrug

Antibiotic

Normal salinedrug

50cc intravenous once daily